U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Biologics Evaluation and Research (CBER)
  5. CBER Vision & Mission
  1. Center for Biologics Evaluation and Research (CBER)

CBER Vision & Mission

Vision

The Center for Biologics Evaluation and Research (CBER) uses sound science and regulatory expertise to:

  • Protect and improve public and individual health in the United States and, where feasible, globally;
  • Facilitate the development, approval of, and access to safe and effective products and promising new technologies; and
  • Strengthen CBER as a preeminent regulatory organization for biologics.

Mission

The mission of the Center for Biologics Evaluation and Research (CBER) is to ensure the safety, purity, potency, and effectiveness of biological products including vaccines, allergenics, blood and blood products, and cells, tissues, and gene therapies for the prevention, diagnosis, and treatment of human diseases, conditions, or injury. Through our mission, we also seek to protect the public against the threats of emerging infectious diseases and bioterrorism.

Related Information

Back to Top